Shelby D. Reed, PhD

Professor
Duke Clinical Research Institute
Center for Clinical and Genetic Economics
Duke Clinical Research Institute
PO Box 17969
Durham, NC
USA 27715


Biographical Sketch: Shelby D. Reed, PhD, RPh, is a Professor in the School of Medicine, Division of General Internal Medicine, and Member of the Duke Cancer Institute at Duke University in Durham, NC. Dr. Reed has nearly 20 years of experience in economic evaluation, health services research and health policy. Her research portfolio includes a broad array of trial-based and model-based cost-effectiveness analyses of new and existing medical diagnostics, drugs, devices and patient-centered interventions. With R01 funding from the NIH, she led a team of investigators to develop generalizable web-based economic tools to evaluate costs and cost-effectiveness of disease management programs in heart failure. In addition, she has conducted numerous economic and epidemiological studies using secondary data from health care claims, clinical trials, surveys and disease registries. In her evaluations of health policy issues, she has developed computer models to analyze the potential economic impact of trends in clinical trial design, changes in reimbursement policies, financial incentives and the regulatory process in the development of orphan drugs, and the societal value of alternative approaches to identifying drug safety problems. Emerging areas of focus are conjoint analysis and multi-criteria decision analysis. Over the last couple of years, she has worked on studies examining patients’ preferences with regard to features health care delivery, tradeoffs women with ovarian cancer are willing to make between progression-free survival and toxicities associated with chemotherapy, and patient preferences with regard to surgical versus non-surgical treatment of shoulder dislocation.

Papers:
3H-5 BEWARE THE LAW OF AVERAGES: EVALUATING TASTE HETEROGENEITY IN BENEFIT-RISK TRADEOFF PREFERENCES 5N-3 HOW HETEROGENEOUS ARE PREFERENCES FOR DELAYING ONSET OF ALZHEIMER'S DISEASE: IT DEPENDS ON HOW YOU LOOK